Morgan Stanley’s P3 Health Partners PIII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$71.7K Buy
10,605
+7,785
+276% +$74.9K ﹤0.01% 6442
2026
Q2
$30.5K Buy
+2,820
New +$21K ﹤0.01% 6678
2025
Q3
– Sell
-360
Closed -$2.27K – 8314
2025
Q2
$2.27K Buy
+360
New +$2.82K ﹤0.01% 7202
2024
Q4
– Sell
-38,105
Closed -$736K – 8063
2024
Q3
$736K Buy
38,105
+37,914
+19,850% +$993K ﹤0.01% 5220
2024
Q2
$4.3K Sell
191
-852
-82% -$25.4K ﹤0.01% 6884
2024
Q1
$53.7K Sell
1,043
-1,762
-63% -$97.9K ﹤0.01% 6189
2023
Q4
$198K Buy
2,805
+2,186
+353% +$151K ﹤0.01% 5708
2023
Q3
$45.5K Buy
619
+37
+6% +$3.84K ﹤0.01% 6203
2023
Q2
$87K Buy
582
+349
+150% +$48.2K ﹤0.01% 6009
2023
Q1
$12.3K Sell
233
-99
-30% -$5.95K ﹤0.01% 6812
2022
Q4
$30.6K Sell
332
-167
-33% -$36.2K ﹤0.01% 6506
2022
Q3
$116K Buy
499
+187
+60% +$46.8K ﹤0.01% 6005
2022
Q2
$58K Buy
312
+240
+333% +$66.9K ﹤0.01% 6548
2022
Q1
$27K Buy
+72
New +$21.6K ﹤0.01% 7011
2021
Q4
– Sell
-3
Closed -$2K – 8074
2021
Q3
$2K Buy
3
+1
+50% +$493 ﹤0.01% 7674
2021
Q2
$1K Buy
+2
New +$981 ﹤0.01% 7621

Other funds holding PIII

Morgan Stanley's PIII Position: Q3 2026 in Review

Morgan Stanley increased its P3 Health Partners (PIII) stake by 276% in Q3 2026, buying an estimated $74.9K and bringing the position to 10,605 shares worth $71.7K. The position accounts for ﹤0.01% of the portfolio, ranked #6442.

Morgan Stanley first reported a position in PIII in Q2 2021 and has held it in 16 quarters since. The position peaked at $736K in Q3 2024. 17 funds tracked by Wall St. Rank hold PIII as of Q3 2026.

  • Morgan Stanley held 10,605 shares of P3 Health Partners worth $71.7K as of Q3 2026.
  • Morgan Stanley bought 7,785 P3 Health Partners shares in Q3 2026, an estimated $74.9K.
  • P3 Health Partners made up ﹤0.01% of Morgan Stanley's portfolio in Q3 2026, its #6442 holding.
  • Morgan Stanley first reported a position in P3 Health Partners in Q2 2021 and has held it in 16 quarters since.
  • Morgan Stanley's P3 Health Partners position peaked at $736K in Q3 2024.
  • 17 funds tracked by Wall St. Rank held P3 Health Partners as of Q3 2026.

Based on Morgan Stanley's 13F filing for Q3 2026, filed 13 Nov 2026.